Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-01-26
2010-12-28
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07858655
ABSTRACT:
The present invention concerns the use of Provided is a drug composition and a method for using the composition for the prevention and the therapy of neurodegenerative diseases. The combination comprises at least two of the following substances: α-lipoic acid; ambroxol and one or several inhibitor(s) of the angiotension-converting enzyme (ACE).
REFERENCES:
patent: 2002/0177558 (2002-11-01), Meyerhoff et al.
patent: WO 02/096398 (2002-12-01), None
patent: WO 02/096414 (2002-12-01), None
Gillissen et al., Respiratory Med. (1998), vol. 92, pp. 609-623.
Derick et al., Biochem. Biophy. Research Comm. (1995), vol. 207, No. 1, pp. 258-264.
Elena et al., Am. J. Physiol. Regulatory Integrative Comp. Physiol., (2000), vol. 278, pp. R572-R577.
Biewenga et al., Gen, Pharm, (1997), vol. 29(3), pp. 315-331.
Jablonka, Stanislaw, Andrzej Ledwozyw, Wojciech Kadziolka, Andrzej Jablonka, and Andrzej Nestorowicz, “The Influence Of Ambroxol On Peroxidative Processes In Lung And Plasma In Dogs After Pulmonectomy,”Archivum Veterinarium Polonicum, 1992, pp. 57-66, vol. 32, No. 1-2.
Kozhevnikova, E.V. and L.M. Adzhienko, “Neuroprotective Activity Of Angiotensin-Converting Enzyme Inhibitors In Cerebral Ischemia,”Bulletin Of Experimental Biology And Medicine, 1999, pp. 1122-1124, vol. 11.
Packer, Lester, Hans J. Tritschler, and Klaus Wessel, “Neuroprotection By The Metabolic Antioxidant α-Lipoic Acid,”Free Radical Biology&Medicine, 1997, pp. 359-378, vol. 22, No. ½.
Ravati, Alexander, Vera Junker, Maria Kouklei, Barbara Ahlemeyer, Carsten Culmsee, and Josef Krieglstein, “Enalapril And Moexipril Protect From Free Radical-Induced Neuronal Damage In Vitro And Reduce Ischemic Brain Injury In Mice And Rats,”European Journal Of Pharmacology, 1999, pp. 21-33, vol. 373.
Stoll, S., A. Rostock, R. Bartsch, E. Korn, A. Meichelböock, and W.E. Müller, “The Potent Free Radical Scavenger α-Lipoic Acid Improves Cognition In Rodents,”Annals New York Academy Of Sciences, 1994, pp. 122-128.
Werner, Christian, William E. Hoffman, Eberhard Kochs, Sara F. Rabito, and David J. Miletich, “Captopril Improves Neurologic Outcome From Incomplete Cerebral Ischemia In Rats,”Stroke, Jul. 1991, pp. 910-914, vol. 22, No. 7.
Ansorge Siegfried
Reymann Klaus
Röhnert Peter
Schröder Ulrich
Striggow Frank
Hodgson & Russ LLP
Keyneurotek Pharmaceuticals AG
Solola Taofiq A
LandOfFree
Drug preparation comprising α-lipoic acid, ambroxol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug preparation comprising α-lipoic acid, ambroxol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug preparation comprising α-lipoic acid, ambroxol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206843